or Try an Advanced Search...

    Technical Analysis for ELDN - Eledon Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    C 3.85 -0.77% -0.03
    ELDN closed down 0.77 percent on Wednesday, November 20, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical ELDN trend table...
    Date Alert Name Type % Chg
    New Uptrend Bullish 0.00%
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.77%
    Stochastic Reached Oversold Weakness -0.77%
    Inside Day Range Contraction -0.77%
    Older End-of-Day Signals for ELDN ...

       Recent Intraday Alerts

    Alert Time
    Outside Day about 15 hours ago
    Down 3% about 15 hours ago
    Fell Below Previous Day's Low about 15 hours ago
    Down 2 % about 15 hours ago
    Down 1% about 15 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ELDN Chart by TradingView
    Basic chart:

    Profile

    Eledon Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. The company's lead product is OP0201, a surfactant-based nasal aerosol drug-device combination product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). It also has a foam-based drug delivery technology OP0101 and OP0102 that could be used to deliver drugs into the ear, nose, and sinus cavities. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Health Sciences Medication Infection Disorders Sinus Audiology Pediatrics Otorhinolaryngology Pernix Therapeutics Holdings

    Is ELDN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions
    Nov 13 Eledon Pharmaceuticals GAAP EPS of -$0.32 misses by $0.02
    Nov 12 Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
    Nov 6 Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
    Oct 29 Eledon: Changing Scope Of Immunosuppressive Drug Space With Tegoprubart
    Oct 29 Eledon Pharmaceuticals prices 18.36M shares at $3.65 in underwritten offering
    Oct 29 Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
    Oct 29 Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
    Sep 11 Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference
    Jul 29 Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection
    See more ELDN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.54
    52 Week Low 1.1099
    Average Volume 449,631
    200-Day Moving Average 2.60
    50-Day Moving Average 3.34
    20-Day Moving Average 4.33
    10-Day Moving Average 4.36
    Average True Range 0.38
    RSI (14) 47.09
    ADX 34.75
    +DI 19.50
    -DI 18.83
    Chandelier Exit (Long, 3 ATRs) 4.39
    Chandelier Exit (Short, 3 ATRs) 4.10
    Upper Bollinger Bands 5.54
    Lower Bollinger Band 3.12
    Percent B (%b) 0.3
    BandWidth 55.96
    MACD Line 0.19
    MACD Signal Line 0.36
    MACD Histogram -0.1658
    Fundamentals Value
    Market Cap 93.16 Million
    Num Shares 24.2 Million
    EPS -5.44
    Price-to-Earnings (P/E) Ratio -0.71
    Price-to-Sales 0.00
    Price-to-Book 0.45
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.47
    Resistance 3 (R3) 4.50 4.34 4.36
    Resistance 2 (R2) 4.34 4.18 4.32 4.33
    Resistance 1 (R1) 4.09 4.08 4.01 4.06 4.29
    Pivot Point 3.93 3.93 3.89 3.91 3.93
    Support 1 (S1) 3.68 3.77 3.60 3.65 3.41
    Support 2 (S2) 3.52 3.67 3.50 3.37
    Support 3 (S3) 3.27 3.52 3.34
    Support 4 (S4) 3.24